Scrip    Clinica    RAJ    Scrip Clinical Research    AnimalPharm
Email ID
Password
Forgotten your password?
Home
Therapy Sector
Generics
Business
Policy & Regulation
Research & Development
International
Cancer
|
Cardiovascular
|
Infection
|
Metabolic
|
Musculoskeletal
|
CNS
|
Respiratory
|
Gastrointestinal
|
Other
|
Therapy Sector - Infection
EVENTS
Today
Cambridge, UK
17 March 2010
Berlin, Germany
17 March 2010
Berlin, Germany
JOB OF THE WEEK Promote your vacancy here
DIRECTORY Scrip Directory 2009
India reports 741 polio cases in 2009
Today
India has reported 741 cases of polio in 2009 (up from 559 in 2008), with the two states of Uttar Pradesh and Bihar reporting the bulk of these. As of February 26th this year, the country had reported 16 cases of the enterovirus. Uttar Pradesh ...
Novartis takes option on Transgene's lung cancer immunotherapy
10 March 2010
Transgene of France has signed an exclusive option agreement with Novartis for the development and commercialisation of the targeted immunotherapy product TG4010 for the first-line treatment of non-small cell lung cancer (NSCLC) and other potential ...
FDA: final guidance on developing cell-based viral vaccines
09 March 2010
The US FDA recognises emerging and pandemic threats – and it aims to boost the development of cell-based viral vaccines with the publication of a final guidance entitled Guidance for Industry: Characterization and Qualification of Cell Substrates ...
GSK sees more value in licensing than AIDS patent pool
09 March 2010
GlaxoSmithKline, which has yet to decide on whether or not to participate in UNITAID 's AIDS medicines patent pool, sees more value in its own licensing approach for HIV/AIDS drugs at present. GSK chief executive Andrew Witty , who was in India to ...
Japanese launch for heptavalent Prevenar
26 February 2010
Wyeth ( Pfizer ) has launched the standard heptavalent version of its paediatric pneumococcal vaccine Prevenar in Japan, for the prevention of invasive pneumococcal disease in infants and young children. The vaccine protects against infections, ...
 
Market Insight - Downturn leaves HIV/AIDS funds feeling the pinch
09 February 2010
The global economic crisis has had a significant negative impact on all areas of life, including labour and property markets, national banking systems and the prices of consumer goods. With so many ...
Market Insight - Differentiation guiding firms through maze of hepatitis C drug development
22 January 2010
The therapeutic landscape in HCV treatment is at an inflection point – recent data from the first generation of protease inhibitors promise the dawn of a new standard of care. But do not expect to ...
Challenges and opportunities in the Philippine pharma market
08 January 2010
On the face of it, the Philippines should be an attractive market for multinational pharmaceutical companies. There is a well-established healthcare system that covers the majority of the population ...
 
Face to face: Ex-Novartis manager takes two-step approach to women's health at Lumavita
12 January 2010
Many pharmaceutical and biotech companies devote themselves to the discovery and development of novel drugs for unmet medical needs. However, with R&D costs and regulatory hurdles multiplying, and ...
Basilea set for success as Toctino roll-out sees revenues surge
26 October 2009
Basilea Pharmaceuticals is currently targeting profitability by around 2012 and has prioritised its research programmes to ensure it becomes a successful hospital and speciality products-focused ...
Cellectis: Partner search is on for meganuclease technology
25 September 2009
The French genome engineering company Cellectis is generating good publicity for its meganuclease technology following its recent deal with Servier for the use of its ∏10 research kit. Scrip's Sita ...
 
Commentary: Asia's largest pharma event remarkably upbeat
08 July 2009
If spotless stainless steel manufacturing equipment and high-tech hardware stretching as far as the eye can see is your thing, the BioForum & BioExpo Japan exhibition held in Tokyo last week was the ...
Latvia makes healthcare budget cuts as economic crisis bites
16 June 2009
Do you have any stress relieving tablets? Latvian pharmacists hear this question more and more frequently, as their patients try to cope with intensifying economic and life problems. Latvia has ...
Cancer drugs: getting more for your money – by Karol Sikora
11 May 2009
Cancer treatment is undergoing a revolution, driven by ageing populations, advanced technologies and an increasingly informed society. Health economics considerations and top-up payments are gaining ...
 
Clinical immunotoxicity of therapeutic proteins
11 May 2009
Therapeutic proteins are proteins engineered in the laboratory for pharmaceutical use. Although they tend to offer a better safety margin than most synthetic small molecules because they are ...
Clevudine: a promising therapy for the treatment of chronic hepatitis B
01 December 2008
Chronic hepatitis B virus (HBV) infection, affecting ∼ 350 million people worldwide, is associated with significant morbidity and mortality. In the past 10 years, hepatitis B therapy research has led ...
Meningococcal tetravalent conjugate vaccine
01 December 2008
Background: Neisseria meningitidis is a leading cause of meningitis and sepsis worldwide. Since 1981, a tetravalent meningococcal polysaccharide vaccine has been available in the US but it has been ...
 
COMPANY/ORGANISATION
CONDITION
GEOGRAPHY
DRUG
© 2010 Informa plc. All rights reserved.
This site is owned and operated by Informa plc ("Informa") whose registered office is Mortimer House, 37-41 Mortimer Street, London, W1T 3JH. Registered in England and Wales. Number 3099067. UK VAT Group: GB 365 4626 36
Home
Therapy Sector
Generics
Business
Policy & Regulation
Research & Development
International
Terms & Conditions
Privacy Policy
Sitemap
About Us
Advertise
Subscribe
Scrip
Clinica
RAJ
Scrip Clinical Research
Animal Pharm